185 related articles for article (PubMed ID: 8951884)
21. Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptors occupancy.
Delay-Goyet P; Ruiz-Gayo M; Baamonde A; Gacel G; Morgat JL; Roques BP
Pharmacol Biochem Behav; 1991 Jan; 38(1):155-62. PubMed ID: 1850135
[TBL] [Abstract][Full Text] [Related]
22. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
[TBL] [Abstract][Full Text] [Related]
23. Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for delta opioid receptors.
Gacel G; Daugé V; Breuzé P; Delay-Goyet P; Roques BP
J Med Chem; 1988 Oct; 31(10):1891-7. PubMed ID: 2845081
[TBL] [Abstract][Full Text] [Related]
24. Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors.
Maldonado R; Feger J; Fournié-Zaluski MC; Roques BP
Brain Res; 1990 Jun; 520(1-2):247-54. PubMed ID: 2169953
[TBL] [Abstract][Full Text] [Related]
25. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
[TBL] [Abstract][Full Text] [Related]
26. Morphine-induced in vivo release of spinal cholecystokinin is mediated by delta-opioid receptors--effect of peripheral axotomy.
Gustafsson H; Afrah AW; Stiller CO
J Neurochem; 2001 Jul; 78(1):55-63. PubMed ID: 11432973
[TBL] [Abstract][Full Text] [Related]
27. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
Lohmann AB; Welch SP
Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the structural parameters involved in the mu and delta opioid receptor discrimination of linear enkephalin-related peptides.
Gacel G; Zajac JM; Delay-Goyet P; Daugé V; Roques BP
J Med Chem; 1988 Feb; 31(2):374-83. PubMed ID: 2828622
[TBL] [Abstract][Full Text] [Related]
29. The mu rather than the delta subtype of opioid receptors appears to be involved in enkephalin-induced analgesia.
Chaillet P; Coulaud A; Zajac JM; Fournie-Zaluski MC; Costentin J; Roques BP
Eur J Pharmacol; 1984 May; 101(1-2):83-90. PubMed ID: 6086366
[TBL] [Abstract][Full Text] [Related]
30. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
Olianas MC; Onali P
Mol Pharmacol; 1992 Jul; 42(1):109-15. PubMed ID: 1321951
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systemically active agonist for in vivo studies of delta-opioid receptors.
Gacel GA; Fellion E; Baamonde A; Dauge V; Roques BP
Peptides; 1990; 11(5):983-8. PubMed ID: 1980943
[TBL] [Abstract][Full Text] [Related]
32. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
33. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
34. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord.
Mauborgne A; Lutz O; Legrand JC; Hamon M; Cesselin F
J Neurochem; 1987 Feb; 48(2):529-37. PubMed ID: 2432185
[TBL] [Abstract][Full Text] [Related]
35. Endogenous opiates and behavior: 2012.
Bodnar RJ
Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
[TBL] [Abstract][Full Text] [Related]
36. Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia.
Rady JJ; Holmes BB; Tseng LF; Fujimoto JM
J Pharmacol Exp Ther; 2001 May; 297(2):582-9. PubMed ID: 11303046
[TBL] [Abstract][Full Text] [Related]
37. Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects.
Smadja C; Maldonado R; Turcaud S; Fournie-Zaluski MC; Roques BP
Psychopharmacology (Berl); 1995 Aug; 120(4):400-8. PubMed ID: 8539320
[TBL] [Abstract][Full Text] [Related]
38. Supraspinal delta 2 opioid agonist analgesia in Swiss-Webster mice involves spinal GABAA receptors.
Rady JJ; Fujimoto JM
Pharmacol Biochem Behav; 1996 Jun; 54(2):363-9. PubMed ID: 8743596
[TBL] [Abstract][Full Text] [Related]
39. Kinetic parameters of antagonism by the delta opioid receptor selective peptide antagonist Boc-Tyr-Pro-Gly-Phe-Leu-Thr against selective and non-selective agonists in the mouse vas deferens.
Rónai AZ; Magyar A; Medzihradszky K
Neuropeptides; 1993 Aug; 25(2):127-9. PubMed ID: 8413857
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
